P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 214 000 KRW -2.28%
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Relative Value

The Relative Value of one PharmaResearch Co Ltd stock under the Base Case scenario is 228 609.4 KRW. Compared to the current market price of 214 000 KRW, PharmaResearch Co Ltd is Undervalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
228 609.4 KRW
Undervaluation 6%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
63
Median 3Y
5
Median 5Y
5.1
Industry
8.1
Forward
6.6
vs History
1
vs Industry
8
Median 3Y
17.4
Median 5Y
18.9
Industry
23
Forward
21.9
vs History
12
vs Industry
9
Median 3Y
14.7
Median 5Y
17.2
Industry
23.4
vs History
33
vs Industry
7
Median 3Y
24
Median 5Y
32
Industry
27.3
vs History
0
vs Industry
29
Median 3Y
2.8
Median 5Y
2.6
Industry
2.6
vs History
0
vs Industry
56
Median 3Y
4.4
Median 5Y
4.6
Industry
8.1
Forward
6.1
vs History
0
vs Industry
49
Median 3Y
6.2
Median 5Y
6.5
Industry
9.6
vs History
0
vs Industry
9
Median 3Y
11.2
Median 5Y
12
Industry
4.3
Forward
15
vs History
3
vs Industry
8
Median 3Y
13.2
Median 5Y
15.1
Industry
3.8
Forward
16.5
vs History
11
vs Industry
10
Median 3Y
12.9
Median 5Y
15.2
Industry
6
vs History
38
vs Industry
7
Median 3Y
18.5
Median 5Y
23.4
Industry
3.8
vs History
0
vs Industry
38
Median 3Y
2.9
Median 5Y
2.6
Industry
4.8

Multiples Across Competitors

Competitors Multiples
PharmaResearch Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
PharmaResearch Co Ltd
KOSDAQ:214450
2.3T KRW 7.4 24.3 18 20.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
KR
P
PharmaResearch Co Ltd
KOSDAQ:214450
Average P/E: 181.8
24.3
97%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
P
PharmaResearch Co Ltd
KOSDAQ:214450
Average EV/EBITDA: 18
18
89%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
P
PharmaResearch Co Ltd
KOSDAQ:214450
Average EV/EBIT: 22.9
20.2
99%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top